ARTICLE | Company News
Dendreon, Covance manufacturing deal
April 5, 2001 7:00 AM UTC
CVD subsidiary Covance Biotechnology Services will produce antigen in commercial quantities for use in preparing DNDN's Provenge activated autologous dendritic cell therapy. The product in Phase III t...